NAP1L1 is a prognostic biomarker and contribute to...

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

Le, Yong, Kan, Anna, Li, Qi-Jiong, He, Min-Ke, Chen, Hai-Long, Shi, Ming
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Journal:
Cancer Cell International
DOI:
10.1186/s12935-019-0949-0
Date:
December, 2019
File:
PDF, 2.03 MB
2019
Conversion to is in progress
Conversion to is failed